Abstract
Kallikrein activity in human stomach tissue was measured and found to be about threefold higher in cancer tissue than in normal tissue. To clarify the physiological role of this tissue kallikrein, we investigated its effects on the spontaneous metastasis and tumor growth of Lewis tumors (3LL). Antiprotease, aprotinin, and gabexate mesilate (FOY) inhibited spontaneous metastasis but did not inhibit tumor growth, while tissue kallikrein and plasmin enhanced the spontaneous metastasis of 3LL. The results suggest that the inhibitory effects of aprotinin and FOY on metastasis are not only due to an inhibition of tumor cells released by tissue kallikrein, but that tissue kallikrein, a protease, also participates in metastasis. We thus conclude that aprotinin or FOY should be administered either before or immediately after operation to inhibit spontaneous metastasis.
Similar content being viewed by others
References
Werle E, Rodin P (1936) Uber das Vorkommen von Kallikrein in den Speicheldrusen und Mundspeichel. Biochem Z 286:213–219
Brandzaeg P, Grautvik KM, Nustad K, Pierce JV (1976) Rat submandibular gland kallikreins: Purification and cellular localization. Br J Pharmacol 56:155–167
Kraut HE, Frey EK, Werle E (1930) Der Nachweis eines Kreislaufhormons in der Pankreasdruse. Z Physiol Chem 189:97–106
Amouric M, Figarella C (1972) Characterization and purification of a kallikrein from human pancreatic juice and immunological comparison with other kallikreins. Hoppe-Seyler's Z Physiol Chem Bd 360:457–465
Seki T, Nakajima T, Erdos EG (1972) Colon kallikrein, its relation to the plasma enzyme. Biochem Pharmacol 21:1227–1235
Frankish NH, Zeitlin IJ (1977) The assay of tissue kallikrein in rat intestine. Br J Pharmacol 59:517P
Uetsuji S, Yamamura M, Yamamoto M, Uchida K, Kushiro H, Kodama J, Fujii S (1972) Human stomach kallikrein. In: Fritz H, Dietze G, Fiedler F, et al. (eds) Recent progress on kinins. Birkhausar Basel
Weiss L (1977) Cell detachment and metastasis. Gann Monogr Cancer Res 20:25–35
Chong MT, Garrard WT, Bonner J (1974) Purification and properties of a neutral protease from rat liver chromatin. Biochemistry 13:5128–5134
Otto K (1967) Uber ein neues Kathepsin. Hoppe-Seyler's Z Physiol Chem 348:1449–1460
Fujii S, Okuda H (1975) New method for estimation of various deaminases by direct colorimetric determination of ammonia. Tokushima J Exp Med 22:1–4
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–276
Weiss L (1977) A pathologic overview of metastasis. Semin Oncol 4:5–17
Strauli P, Barret A, Baici A (eds) (1980) Proteinases and tumor invasion. Raven New York
Tuner GA, Weiss L (1981) Analysis of aprotinin-induced enhancement of metastasis of Lewis lung tumors in mice. Cancer Res 41:2576–2580
Cagliani P, Marino V, Starza M (1962) Administration of fibrinolysis activators and anti-fibrinolysis and the hematogenic spread of Walker carcinosarcoma metastasis. Biol Lat 15:171–174
Cliffton EE, Agostino D (1964) Effect of inhibitors of fibriolytic enzymes on development of pulmonary metastasis. J Natl Cancer Inst 33:753–763
Freeman JG, Venables CW, Turner GA, Latner AL (1980) Aprotinin therapy of gastric cancer. Br Soc Gastroentrol 21:A902
Dunn JR, Honn KV (1981) Lysosomal cathepsin B: Correlation with metastatic potential. Science 212:1151–1153
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uetsuji, S., Yamamura, M., Takai, S. et al. Effect of aprotinin on metastasis of lewis lung tumor in mice. Surg Today 22, 439–442 (1992). https://doi.org/10.1007/BF00308795
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00308795